Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Applied Occupational and Environmental Hygiene
|
June 21, 2001
Development of sampling and analytical methods for concerted determination of commonly used chloroacetanilide, chlorotriazine, and 2,4-D herbicides in hand-wash, dermal-patch, and air samples
S P Tucker, J M Reynolds, D C Wickman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation
K K Fields, G J Elfenbein, W L Trudeau, et al.
Seminars in Oncology
|
October 1, 1993
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities
K K Fields, G J Elfenbein, J B Perkins, et al.
Seminars in Oncology
|
October 1, 1994
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion
K K Fields, G J Elfenbein, J B Perkins, et al.
Bone Marrow Transplantation
|
July 1, 1996
Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery
O F Ballester, D P Agaliotis, J W Hiemenz, et al.
The American Journal of the Medical Sciences
|
November 20, 1997
Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation
D P Agaliotis, O F Ballester, T Mattox, et al.
Seminars in Oncology
|
May 13, 1998
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer
K K Fields, G J Elfenbein, J B Perkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile
K K Fields, G J Elfenbein, H M Lazarus, et al.
Bone Marrow Transplantation
|
January 31, 1998
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency
O F Ballester, R Tummala, W E Janssen, et al.
Bone Marrow Transplantation
|
September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission
G Kunter, J B Perkins, J Pidala, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Applied Occupational and Environmental Hygiene
|
June 21, 2001
Development of sampling and analytical methods for concerted determination of commonly used chloroacetanilide, chlorotriazine, and 2,4-D herbicides in hand-wash, dermal-patch, and air samples
S P Tucker, J M Reynolds, D C Wickman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation
K K Fields, G J Elfenbein, W L Trudeau, et al.
Seminars in Oncology
|
October 1, 1993
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities
K K Fields, G J Elfenbein, J B Perkins, et al.
Seminars in Oncology
|
October 1, 1994
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion
K K Fields, G J Elfenbein, J B Perkins, et al.
Bone Marrow Transplantation
|
July 1, 1996
Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery
O F Ballester, D P Agaliotis, J W Hiemenz, et al.
The American Journal of the Medical Sciences
|
November 20, 1997
Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation
D P Agaliotis, O F Ballester, T Mattox, et al.
Seminars in Oncology
|
May 13, 1998
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer
K K Fields, G J Elfenbein, J B Perkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile
K K Fields, G J Elfenbein, H M Lazarus, et al.
Bone Marrow Transplantation
|
January 31, 1998
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency
O F Ballester, R Tummala, W E Janssen, et al.
Bone Marrow Transplantation
|
September 3, 2013
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission
G Kunter, J B Perkins, J Pidala, et al.
Page
of 3